A detailed history of Russell Investments Group, Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 699 shares of BNTX stock, worth $82,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
699
Previous 699 -0.0%
Holding current value
$82,055
Previous $56,000 48.21%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$90.91 - $112.75 $37,182 - $46,114
-409 Reduced 36.91%
699 $73,000
Q3 2023

Nov 13, 2023

SELL
$98.5 - $125.08 $384,150 - $487,812
-3,900 Reduced 77.88%
1,108 $120,000
Q2 2023

Aug 10, 2023

BUY
$102.58 - $129.66 $41,955 - $53,030
409 Added 8.89%
5,008 $540,000
Q1 2023

May 09, 2023

SELL
$122.57 - $153.67 $1.02 Million - $1.28 Million
-8,361 Reduced 64.51%
4,599 $572,000
Q4 2022

Feb 08, 2023

SELL
$118.43 - $186.05 $255,571 - $401,495
-2,158 Reduced 14.27%
12,960 $1.95 Million
Q3 2022

Nov 04, 2022

BUY
$127.65 - $183.11 $1.38 Million - $1.97 Million
10,784 Added 248.82%
15,118 $2.02 Million
Q2 2022

Jul 29, 2022

SELL
$123.25 - $186.24 $122,880 - $185,681
-997 Reduced 18.7%
4,334 $639,000
Q1 2022

May 05, 2022

BUY
$126.25 - $231.85 $13,382 - $24,576
106 Added 2.03%
5,331 $909,000
Q4 2021

Jan 21, 2022

SELL
$216.64 - $362.52 $3.33 Million - $5.58 Million
-15,391 Reduced 74.66%
5,225 $1.35 Million
Q3 2021

Nov 08, 2021

SELL
$205.93 - $447.23 $4.72 Million - $10.3 Million
-22,932 Reduced 52.66%
20,616 $5.68 Million
Q2 2021

Aug 04, 2021

BUY
$113.32 - $241.49 $4.61 Million - $9.83 Million
40,725 Added 1442.61%
43,548 $9.87 Million
Q1 2021

May 10, 2021

BUY
$85.73 - $119.5 $242,015 - $337,348
2,823 New
2,823 $308,000
Q3 2020

Nov 09, 2020

SELL
$57.81 - $104.17 $578,967 - $1.04 Million
-10,015 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$38.58 - $66.74 $386,378 - $668,401
10,015 New
10,015 $668,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.